References
- Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504–507.
- Martina BE, Koraka P, Osterhaus AD. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev. 2009;22(4):564–581.
- Karyanti MR, Uiterwaal CS, Kusriastuti R, et al. The changing incidence of dengue haemorrhagic fever in Indonesia: a 45-year registry-based analysis. BMC Infect Dis. 2014;14:412.
- Shepard DS, Coudeville L, Halasa YA, et al. Economic impact of dengue illness in the Americas. Am J Trop Med Hyg. 2011;84(2):200–207.
- Shepard DS, Undurraga EA, Halasa YA. Economic and disease burden of dengue in Southeast Asia. PLoS Negl Trop Dis. 2013;7(2):e2055.
- Messina JP, Brady OJ, Scott TW, et al. Global spread of dengue virus types: mapping the 70 year history. Trends Microbiol. 2014;22(3):138–146.
- Guy B, Briand O, Lang J, et al. Development of the Sanofi Pasteur tetravalent dengue vaccine: one more step forward. Vaccine. 2015;33(50):7100–7111.
- Poo J, Galan F, Forrat R, et al. Live-attenuated tetravalent dengue vaccine in dengue-naive children, adolescents, and adults in Mexico City: randomized controlled phase 1 trial of safety and immunogenicity. Pediatr Infect Dis J. 2011;30(1):e9–17.
- Guy B, Saville M, Lang J. Development of Sanofi Pasteur tetravalent dengue vaccine. Hum Vaccin. 2010;6(9):696–705.
- Villar L, Dayan GH, Arredondo-Garcia JL, et al. Efficacy of a tetravalent dengue vaccine in children in Latin America. N Engl J Med. 2015;372(2):113–123.
- Capeding MR, Tran NH, Hadinegoro SR, et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet. 2014;384(9951):1358–1365.
- Hadinegoro SR, Arredondo-Garcia JL, Capeding MR, et al. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N Engl J Med. 2015;373(13):1195–1206.
- Guy B, Jackson N. Dengue vaccine: hypotheses to understand CYD-TDV-induced protection. Nat Rev Microbiol. 2016;14(1):45–54.
- Lim JK, Lee YS, Wilder-Smith A, et al. Points for consideration for dengue vaccine introduction – recommendations by the dengue vaccine initiative. Expert Rev Vaccines. 2016;15(4):529–538.
- World Health Organization. Summary of the April 2016 meeting of the Strategic Advisory Group of Experts on immunization (SAGE). 2016 [cited 2016 Apr 25]. Available from: http://www.who.int/immunization/sage/meetings/2016/april/SAGE_April_2016_Meeting_Web_summary.pdf?ua=1
- Coudeville L, Baurin N. Potential impact of dengue vaccination: insights from the first large-scale efficacy trials. Poster presented at 64th ASTMH Annual Meeting; 2015 Oct 25–29; Philadelphia, PA. Poster #3234.
- Mantel C, Wang SA. The privilege and responsibility of having choices: decision-making for new vaccines in developing countries. Health Policy Plan. 2012;27(Suppl 2):ii1–4.
- World Health Organization. School vaccination readiness assessment tool. 2013 [cited 2016 Feb 3]. Available from: http://apps.who.int/iris/bitstream/10665/90566/1/WHO_IVB_13.02_eng.pdf
- World Health Organization. Global Immunization Vision and Strategy. 2011 [cited 2016 Jan 25]. Available form: http://www.who.int/immunization/givs/en/
- Thisyakorn U, Capeding MR, Goh DY, et al. Preparing for dengue vaccine introduction in ASEAN countries: recommendations from the first ADVA regional workshop. Expert Rev Vaccines. 2014;13(5):581–587.
- World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd. Geneva: World Health Organization; 1997 [cited 2015 Apr 1]. Available form http://apps.who.int/iris/bitstream/10665/41988/1/9241545003_eng.pdf
- World Health Organization. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. 2009 [cited 2016 Jan 25]. Available from: http://www.who.int/tdr/publications/documents/dengue-diagnosis.pdf
- Plennevaux E, Sabchareon A, Limkittikul K, et al. Detection of dengue cases by serological testing in a dengue vaccine efficacy trial: utility for efficacy evaluation and impact of future vaccine introduction. Vaccine. 2016;34:2707–2712.
- Torresi J, Tapia-Conyer R, Margolis H. Preparing for dengue vaccine introduction: recommendations from the 1st dengue v2V International Meeting. PLoS Negl Trop Dis. 2013;7(9):e2261.
- World Health Organization. Principles and considerations for adding a vaccine to a national immunization programme. 2014 [cited 2016 Jan 28]. Available from: http://apps.who.int/iris/bitstream/10665/111548/1/9789241506892_eng.pdf?ua=1